Richard F Wallman sold $1.6M of CRL
director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. 7,621 shares at an average of $216.17, traded Nov 7, 2024, filed Nov 12, 2024.
Score components
- +15RoleDirector
- +25Trade size$1.6M at market
- +10Share of holdings soldSold 40% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -10.0%, 3m -28.3%, 6m -33.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-24-027032, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 6, 2024 | GGift Common Stock | -4,540 | $0.00 | $0 | 19,007 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stock | -3,371 | $215.75 | $727k | 15,636 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stock | -3,250 | $216.50 | $704k | 12,386 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Wife | -1,000 | $216.50 | $217k | 0 | Nov 12, 2024 |
Related signals
Other insiders at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Shannon M Parisotto CEVP, Disc & Safety Assessment | $303k 981 shares | -17% | |
| 17Weak | CRLbuy CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Glenn Coleman EVP & Chief Financial Officer | $2,974 10 shares | +0% | |
| 3Weak | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | George Massaro director | $19k 140 shares | -2% | |
| 31Weak | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Joseph W LaPlume EVP, Corp Strategy & Develop | $73k 500 shares | -2% | |
| 3Weak | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | George Massaro director | $20k 140 shares | -2% | |
| 41Moderate | CRLsell CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Joseph W LaPlume EVP, Corp Strategy & Develop | $715k 4,400 shares | -18% | |
| 41Moderate | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Birgit Girshick Corporate Executive VP & COO | $249k 1,514 shares | +3% | |
| 58Moderate | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | James C Foster Chairman, President and CEO | $1.0M 6,075 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.